Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.557NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.557NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.119NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.119NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.160NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.160NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
D.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
D.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.447NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.447NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
A.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.417NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.417NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AM.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AM.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.319NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.319NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.182NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.182NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.430NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.430NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.331NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.331NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F362.924China
B.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.112.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.112.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.77NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.504NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.504NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.201NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.201NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.515NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.515NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.287NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.287NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used